DataMEDS AI Enters Agreement Covering Commercial Supply of Six Peptides
DataMEDS AI says its Corexa Health subsidiary has entered an agreement covering commercial supply of BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax.
Topic Intelligence
Articles and insights tagged Blockchain on FAQSIR.
DataMEDS AI says its Corexa Health subsidiary has entered an agreement covering commercial supply of BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax.
Bluesky Digital Assets Corp. said Frank Kordy has departed as a director, leaving a board vacancy that has not yet been filled.
GameSquare completed its FanEngine transaction, adding rights connected to Peaky Blinders, Simon's Cat and 15 global athletes while reiterating its 2027 financial guidance.
Globa Terra Acquisition Corporation has amended its proposed business-combination extension, including a conditional $0.03 payment for every public share outstanding at its November 9 meeting. The company is also pursuing a proposed Nature's Ledger transaction that remains based on a nonbinding Letter of Intent.
DataMEDS AI has established the Health Lives Here Community Respiratory Program for the Corexa Health Pharmacy Network, with an initial rollout planned at Corexa Pharmacy in Lakeland, Florida.
DataMeds AI received Nasdaq confirmation that it had met the minimum stockholders’ equity requirement under Listing Rule 5550(b)(1). The company said it may still be subject to delisting if its next periodic report does not evidence compliance.
Bluesky Digital Assets Corp. will not proceed with its proposed acquisition and fundamental change transaction with ChessGold Inc. The company also announced changes to its board and executive leadership.
DataMeds AI said its Corexa Health subsidiary is preparing for potential compounded peptide activity while the FDA considers an interim access policy.
DataMeds AI plans to integrate REBOOT Health AI’s licensed care management technology into its Health Lives Here app for patients using GLP-1 receptor agonist medications.